ALK and neuroblastoma: Activating mutations in the anaplastic lymphoma kinase (ALK) gene have been reported in 50% of familial NB (familial NB is rare accounting for around 2% of NB cases) and between 8 and 10% of sporadic neuroblastoma, across all risk groups and occurring more frequently at relapse (42, 78, 80–82).